✦ LIBER ✦

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

✍ Scribed by Boyle, Michael P; Bell, Scott C; Konstan, Michael W; McColley, Susanna A; Rowe, Steven M; Rietschel, Ernst; Huang, Xiaohong; Waltz, David; Patel, Naimish R; Rodman, David

Book ID: 125799584
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 423 KB
Volume: 2
Category: Article
ISSN: 2213-2600
DOI: 10.1016/S2213-2600(14)70132-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WS7.4 Lumacaftor, an investigational CFT

WS7.4 Lumacaftor, an investigational CFTR corrector, in combination with ivacaftor, a CFTR potentiator, in CF patients with the F508del-CFTR mutation: Phase 2 interim analysis

✍ Boyle, M.; Bell, S.C.; Konstan, M.; Colley, S. Mc; Flume, P.; Kang, L.; Wu, Y.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

WS1.1 The effect of ivacaftor, a CFTR po

WS1.1 The effect of ivacaftor, a CFTR potentiator, in patients with cystic fibrosis and a non-G551D-CFTR gating mutation, the KONNECTION study

✍ De Boeck, K.; Munck, A.; Walker, S.; Faro, A.; Hiatt, P.; Chan, J.; Gilmartin, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 70 KB

44 Pulmonary exacerbations in a Phase 3

44 Pulmonary exacerbations in a Phase 3 trial of ivacaftor in subjects with cystic fibrosis who have the G551D-CFTR mutation

✍ M. Griese; B. Ramsey; S. Rodriguez; K. Yen; J.S. Elborn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Assessment of clinical response to ivaca

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial

✍ Davies, Jane; Sheridan, Helen; Bell, Nicholas; Cunningham, Steve; Davis, Stephan 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 423 KB

WS3.2 The effect of ivacaftor treatment

WS3.2 The effect of ivacaftor treatment on lung ventilation defects, as measured by hyperpolarized helium-3 MRI, on patients with cystic fibrosis and a G551D-CFTR mutation

✍ Altes, T.; Johnson, M.; Higgins, M.; Fidler, M.; Botfield, M.; Mugler III, J.P.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB